Here’s some of HealthDay’s top stories for Wednesday, Aug. 4: Full FDA approval for Pfizer vaccine could come by Labor Day. With the Delta variant raging and vaccine hesitancy still an issue, the FDA says it’s taking an “all-hands-on-deck” approach to full approval of Pfizer-BioNTech’s COVID-19 vaccine by early September.Continue Reading
Here’s some of HealthDay’s top stories for Tuesday, Aug. 3: When it comes to doctors, white coats matter. A new survey finds most patients still associate the traditional medical garb with experience and professionalism. Read more Biden’s vaccination goal finally reached. The plan was to get at least one doseContinue Reading
MONDAY, Aug. 2, 2021 (HealthDay News) — Kids who are around people who use marijuana may be at risk for more colds and respiratory infections due to secondhand smoke, according to a new study. In a survey of 1,500 parents and caregivers, those who regularly smoked or vaped marijuana reportedContinue Reading
Here’s some of HealthDay’s top stories for Monday, Aug. 2: Acne more than a teenage plague. It brings to mind adolescents with pimples fueled by surging hormones, but new research shows bad skin takes a huge emotional toll on grown women, both personally and professionally. Read more An ALS drugContinue Reading
Here’s some of HealthDay’s top stories for Friday, July 30: New data details Delta variant’s dangers. Fresh evidence shows the vaccinated may be spreading the variant as easily as the unvaccinated. The research was what prompted the U.S. Centers for Disease Control and Prevention to reverse its mask guidance forContinue Reading
Here’s some of HealthDay’s top stories for Thursday, July 29: Biden to mandate ‘vaccine or testing’ for federal workers. Faced with tough resistance by many Americans to COVID vaccination and a surge in cases driven by the Delta variant, President Joe Biden on Thursday will issue mandatory vaccination or weeklyContinue Reading
Here’s some of HealthDay’s top stories for Wednesday, July 28: FDA advisor who panned new Alzheimer’s drug speaks out. Dr. G. Caleb Alexander was one of 10 advisors on an 11-member FDA panel who voted against approval of the controversial new Alzheimer’s drug, Aduhelm. The agency approved the drug anyway.Continue Reading
WEDNESDAY, July 28, 2021 (HealthDay News) — Trusting science is good, but it could put you at risk for being duped by false science, or “pseudoscience,” if you let your guard down, researchers warn. Investigators found that people who trust science are more likely to believe and share false claimsContinue Reading
TUESDAY, July 27, 2021 (HealthDay News) — There’s been a sharp rise in schizophrenia cases linked with marijuana use since the mid-1990s, a new Danish study finds. Prior research has suggested that marijuana — particularly very heavy use — is associated with an increased risk of schizophrenia. Although strict cause-and-effectContinue Reading
Here’s some of HealthDay’s top stories for Tuesday, July 27: Choosing the best blood pressure drug for you. A study involving data on more than 3 million people focused on two major classes of drugs used to lower high blood pressure — ACE inhibitors and angiotensin receptor blockers (ARBs). DependingContinue Reading